发明名称 |
Therapeutic inhibitor of vascular smooth muscle cells |
摘要 |
Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically effective dosage of a therapeutic conjugate containing a vascular smooth muscle binding protein that associates in a specific manner with a cell surface of the vascular smooth muscle cell, coupled to a therapeutic agent dosage form that inhibits a cellular activity of the muscle cell. Methods are also provided for the direct and/or targeted delivery of therapeutic agents to vascular smooth muscle cells that cause a dilation and fixation of the vascular lumen by inhibiting smooth muscle cell contraction, thereby constituting a biological stent. Also discussed are mechanisms for in vivo vascular smooth muscle cell proliferation modulation, agents that impact those mechanisms and protocols for the use of those agents. |
申请公布号 |
US8067022(B2) |
申请公布日期 |
2011.11.29 |
申请号 |
US20010910388 |
申请日期 |
2001.07.20 |
申请人 |
KUNZ LAWRENCE L.;ANDERSON PETER G.;BOSTON SCIENTIFIC SCIMED, INC. |
发明人 |
KUNZ LAWRENCE L.;ANDERSON PETER G. |
分类号 |
A61F2/00;A61K9/00;A61K31/00;A61K31/135;A61K31/138;A61K31/337;A61K31/40;A61K31/4025;A61K31/4035;A61K31/407;A61K47/48 |
主分类号 |
A61F2/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|